A detailed history of Fmr LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fmr LLC holds 341,829 shares of NBIX stock, worth $41.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
341,829
Previous 232,519 47.01%
Holding current value
$41.8 Million
Previous $32.1 Million 46.74%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$130.86 - $143.19 $14.3 Million - $15.7 Million
109,310 Added 47.01%
341,829 $47.1 Million
Q1 2024

May 13, 2024

SELL
$130.4 - $143.74 $4.18 Million - $4.6 Million
-32,033 Reduced 12.11%
232,519 $32.1 Million
Q4 2023

Feb 13, 2024

BUY
$106.07 - $132.76 $25.7 Million - $32.2 Million
242,547 Added 1102.24%
264,552 $34.9 Million
Q3 2023

Nov 13, 2023

BUY
$94.02 - $117.1 $1.17 Million - $1.45 Million
12,420 Added 129.58%
22,005 $2.48 Million
Q2 2023

Aug 11, 2023

SELL
$89.53 - $104.87 $2.06 Million - $2.41 Million
-22,990 Reduced 70.58%
9,585 $903,000
Q1 2023

May 11, 2023

SELL
$94.11 - $123.02 $71 Million - $92.8 Million
-753,973 Reduced 95.86%
32,575 $3.3 Million
Q4 2022

Feb 13, 2023

BUY
$106.72 - $127.06 $47.4 Million - $56.4 Million
443,868 Added 129.53%
786,548 $93.9 Million
Q3 2022

Nov 10, 2022

BUY
$92.03 - $107.81 $10 Million - $11.8 Million
109,175 Added 46.75%
342,680 $36.4 Million
Q2 2022

Aug 12, 2022

SELL
$75.79 - $100.07 $466,563 - $616,030
-6,156 Reduced 2.57%
233,505 $22.8 Million
Q1 2022

May 13, 2022

SELL
$72.45 - $94.81 $31.5 Million - $41.2 Million
-434,980 Reduced 64.48%
239,661 $22.5 Million
Q4 2021

Feb 14, 2022

SELL
$79.65 - $106.22 $222 Million - $296 Million
-2,790,506 Reduced 80.53%
674,641 $57.5 Million
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $65.8 Million - $75.6 Million
-763,211 Reduced 18.05%
3,465,147 $332 Million
Q2 2021

Aug 13, 2021

BUY
$89.43 - $102.27 $378 Million - $432 Million
4,228,358 New
4,228,358 $412 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.7B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.